PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Li-Huei Tsai, MIT to Speak at Neurodegenerative Conditions Conference on September 9-10 in Boston, Massachusetts - Dr. Li-Huei Tsai, Professor and Director at the Picower Institute for Learning and Memory at MIT, to Give a Keynote Presentation at the 7th Neurodegenerative Conditions Research & Development Conference, September 9-10, 2013 in Boston, MA
Li-Huei Tsai, MIT to Speak at Neurodegenerative Conditions Conference on September 9-10 in Boston, Massachusetts

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/07/09 - Dr. Li-Huei Tsai, Professor and Director at the Picower Institute for Learning and Memory at MIT, to Give a Keynote Presentation at the 7th Neurodegenerative Conditions Research & Development Conference, September 9-10, 2013 in Boston, MA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Li-Huei Tsai, Professor and Director at the Picower Institute for Learning and Memory at MIT, will give a keynote presentation about “Recovery of Cognitive Function Through the Promotion of Chromatin Remodeling in Alzheimer’s Disease Models” at GTC’s 7th Neurodegenerative Conditions Research & Development Conference on September 9-10, 2013 in Boston, MA.

Histone acetylation represents a prominent epigenetic modification of the central nervous system genome that has been unequivocally associated with an increased rate of gene transcription. However, the chromatin enzyme histone deacetylase 2 (HDAC2) negatively regulates the expression of genes essential for synaptic plasticity and memory formation in the central nervous system. Levels of HDAC2 are markedly unregulated in the aged mouse brain, the brain of several mouse models of Alzheimer’s disease (AD), as well as in the human postmortem AD brain. Increases in HDAC2, in turn, lead to a blockade of the expression of genes necessary for synaptic plasticity and eventually constrain cognitive abilities.

Professor Tsai will discuss how reversing the build-up of HDAC2 unlocks this epigenetic blockade of gene expression and abolishes neurodegeneration-associated memory impairments in mouse models of Alzheimer’s disease. These observations indicate that cognitive impairments resulting from neuropathology are readily reversible by manipulations that promote chromatin remodeling.

Li-Huei Tsai received her Ph.D. degree from the University of Texas, Southwestern Medical Center in Dallas. She then took postdoctoral training from Ed Harlow's laboratory at Cold Spring Harbor Laboratory and Massachusetts General Hospital. She joined the faculty in the Department of Pathology at Harvard Medical School in 1994 and was named an investigator at the Howard Hughes Medical Institute in 1997. In 2006, she was appointed Professor in the Department of Brain and Cognitive Sciences, and joined the Picower Institute for Learning and Memory at MIT.

GTC’s 7th Neurodegenerative Conditions Research and Development Conference provides a forum for lead researchers and scientists from industry, academia, government, and patient groups to discuss topics such as tau as a target, the amyloid hypothesis, imaging modalities, and where the field of neuroscience research is heading.

The conference is part of the CNS Diseases World Summit 2013, which includes the 6th CNS Partnering & Deal-Making Conference.

For more information, please visit gtcbio.com/neurodegenerative.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Li-Huei Tsai, MIT to Speak at Neurodegenerative Conditions Conference on September 9-10 in Boston, Massachusetts

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)